DABIGATRAN ETEXILATE (has an active metabolite) | DABIGATRAN ETEXILATE | ATC B01AE07
BLOOD ANTITHROMBOTIC AGENTS THROMBINE INHIBITOR TO REDUCE THE RISK OF STROKE AND SYSTEMIC EMBOLISM IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | ORAL | SOLUBILITY OF 1.8 MILLIGRAM / MILLILITER | PROTHROMBIN | THROMBIN INHIBITOR CHEMBL204 THROMBIN P00734 PROTHROMBIN HOMO SAPIENS ENZYME PROTEASE SERINE PAS S1A | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |